Molecular Diagnostics of Melanoma Fine-Needle Aspirates A Cytology-Histology Correlation Study

ArticleinAmerican Journal of Clinical Pathology 138(5):670-7 · November 2012with4 Reads
DOI: 10.1309/AJCPEQJW3PLOOZTC · Source: PubMed
Abstract
Patients with advanced-stage melanoma harboring a BRAF mutation are candidates for BRAF inhibition as a therapeutic strategy. The use of fine-needle aspiration (FNA) to diagnose metastatic melanoma is increasing. Studies examining the predictive value of BRAF mutation analysis on melanoma FNAs via correlation with follow-up excision findings are lacking. We examined 37 consecutive FNA cases of metastatic melanoma in which the aspirated lesion was subsequently excised. DNA was purified from Diff-Quik-stained FNA smears and tissue blocks from corresponding excisions in parallel. BRAF mutation status was successfully obtained from both specimen types in 34 (92%) of 37 cases. BRAF mutations were detected in 12 (35%) of 34 cases-11 V600E and 1 V600K. Results of BRAF mutational analysis were concordant in all 34 FNA smear/tissue excision pairs. Thus, melanoma FNA for molecular diagnostics represents a rapid, minimally invasive, and effective management strategy in this era of precision medicine.
  • [Show abstract] [Hide abstract] ABSTRACT: Background: Rearrangements involving the anaplastic lymphoma kinase (ALK) gene are present in approximately 5% of lung adenocarcinomas. Crizotinib is approved for the treatment of lung adenocarcinomas harboring ALK rearrangements. Patients with advanced stage lung cancer are not candidates for surgical resection of their primary tumors. For these patients, cytologic specimens often represent the only diagnostic tissue available. Cell blocks (CBs) are routinely used for molecular studies; however, insufficient CB cellularity can impede the performance of these assays. Methods: Thirty-two cytology cases of lung adenocarcinomas were analyzed by fluorescence in situ hybridization (FISH) for ALK rearrangements. Diff-Quik-stained smears were examined to identify tumor cell-enriched areas that were marked using a diamond-tipped scribe. Paired ALK rearrangement FISH was performed using smears and CBs in each case. Results: An ALK rearrangement was detected on direct smears and CB sections in 5 (16%) and 4 (13%), respectively, of the 32 cases studied. Concordant FISH results for smears and CBs were observed in 31 (97%) of 32 cases. In the 1 discordant case, an ALK rearrangement was detected on the direct smear but not in the CB. Reverse transcriptase-polymerase chain reaction analysis of this CB revealed the presence of an EML4-ALK rearrangement, thereby confirming a false-negative FISH result in the CB. Conclusions: Stained cytologic direct smears can be effectively used for ALK rearrangement analysis by FISH. This approach represents a useful safeguard when insufficient CB cellularity is encountered and could prevent delays in treatment in this era of precision medicine.
    Article · Sep 2013
  • [Show abstract] [Hide abstract] ABSTRACT: In patients with advanced-stage cancer, small biopsies including fine-needle aspirates may be the only opportunity to obtain diagnostic tissue. In the current era of precision medicine, there is an increasing emphasis on the performance of ancillary molecular tests that can provide insights into prognosis and targeted chemotherapeutic options for patient management. Cytopathologists must meet this challenge by accurately diagnosing these fine-needle aspirates and ensuring that adequate material has been obtained for anticipated molecular studies. Herein, we describe a case of a fine-needle aspiration illustrating these principles, especially focusing on the utilization of direct smears for ancillary studies.
    Article · Sep 2013
  • [Show abstract] [Hide abstract] ABSTRACT: Melanoma will eventually recur in approximately 15-35 % of patients [1-6]. Metastases are not usually detected until after diagnosis of the primary tumor, but occasionally patients present with metastatic disease without a known primary tumor or with synchronous metastases at the time of diagnosis of the primary tumor. The interval between removal of the primary tumor and identification of initial metastases is usually less than 3 years but is very variable and can, on rare occasion, be more than 30 years [7, 8]. Melanoma can spread by direct local invasion, along anatomical structures such as vascular channels or nerves, through an intra- or perilymphatic route or hematogenously. © 2014 Springer-Verlag Berlin Heidelberg. All rights are reserved.
    Article · Dec 2013 · Archives of pathology & laboratory medicine
Show more